CluePoints Newsroom

Serving up the latest news and information about CluePoints

View all of our News Articles
BlogCOVID-19
March 30, 2020

Complimentary COVID-19 Risk Assessment Package Available To All at No Cost

As advised in the coronavirus guidances recently issued by FDA, EMA, and MHRA, it is important to perform a fresh risk assessment for each study…
Gemma Telfer
0
BlogNews
March 18, 2020

CluePoints’ Central Statistical Monitoring Supports Business Continuity as Coronavirus Impacts Clinical Trial Operations

MITIGATING THE IMPACT ON SITE MONITORING EFFORTS DUE TO COVID-19 King of Prussia, PA  – March 18, 2020: CluePoints, the premier provider of Risk-Based Trial…
Gemma Telfer
0
Blog
March 17, 2020

Registration Open for our Risk-Based Quality Management Insights Webinar

Please join us for our March 31, 2020 webinar: RBQM Insights - Understanding the Critical Importance of Early Risk Detection (With a Special Feature Addressing…
Gemma Telfer
0
Blog
February 25, 2020

Risk-Based Quality Management – It’s now a Question of “how” Rather than “if”

Risk-based quality management (RBQM) solutions offer sponsors and CROs a better way of detecting and managing risks that may impact the outcome of clinical trials.…
Gemma Telfer
0
Blog
December 10, 2019

Implementing a Risk-Based Quality Management Strategy – The Ultimate Guide

Every organization faces unique challenges when it comes to implementing a Risk-Based Quality Management strategy. There’s no ‘one-size-fits-all’ approach that will ensure success, as each organization…
Gemma Telfer
0
AwardsBlogNews
December 5, 2019

CluePoints’ Risk-Based Quality Management (RBQM) Software Wins at Scrip Awards 2019

King of Prussia, PA – December 5, 2019: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, today…
Gemma Telfer
0

Events

Find out where we’re headed next.

Visit our Events Section

Featured Whitepaper

ICH E6 (R2)
Summary
Paper

Created in conjunction with our peers at TUFTS Center for the Study of Drug Development, this paper provides insights on how companies are responding to ICH E6 (R2) and information on the key themes on adoption.

Learn More

Featured Webinar

ICH E6 (R2)
Webinar
Series

This recorded webinar covers all of the frequently asked Questions about ICH E6 (R2), Risk-Based Study Execution (RBx) and what’s required from a people, process & technology standpoint.

Learn More

We're Kind of a Big Deal.

2,500

Platform Users

350

Studies De-Risked

15,000

Issues Detected